-0.26%
9.77%
5.35%
0.55%
28.12%
18.35%
47.24%
AI Spotlight on ALC
Company Description
Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide.The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures.Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under the PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery.
Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands.The company was formerly known as Alcon Universal S.A. and changed the name to Alcon Inc.in December 2001.
Alcon Inc.was founded in 1945 and is headquartered in Geneva, Switzerland.
Market Data
| Last Price | 83.84 |
| Change Percentage | -0.26% |
| Open | 83.44 |
| Previous Close | 84.06 |
| Market Cap ( Millions) | 41358 |
| Volume | 159066 |
| Year High | 85.34 |
| Year Low | 64.68 |
| M A 50 | 77.29 |
| M A 200 | 79.53 |
Financial Ratios
| FCF Yield | 2.37% |
| Dividend Yield | 0.29% |
| ROE | 7.45% |
| Debt / Equity | 0.00% |
| Net Debt / EBIDTA | -71.39% |
| Price To Book | 0 |
| Price Earnings Ratio | 39.33 |
| Price To FCF | 42.12 |
| Price To sales | 4.6 |
| EV / EBITDA | 20.05 |
News
- Dec -31 - Alcon to Present at 2025 Annual J.P. Morgan Healthcare Conference
- Dec -17 - Alcon Top Pick for 2025 at Needham, added to Conviction List
- Dec -03 - Alcon Inc. (ALC): A Bull Case Theory
- Nov -14 - Alcon Inc (ALC) Q3 2024 Earnings Call Highlights: Record Cash Flow and Strategic Product ...
- Nov -13 - Alcon Q3 Earnings Top Estimates, Margins Up, Stock Gains in Afterhours
- Nov -12 - Alcon (ALC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
- Nov -12 - Alcon Reports Solid Third-Quarter 2024 Results, including Double-Digit Earnings Growth and Record Cash Generation
- Nov -07 - What Analyst Projections for Key Metrics Reveal About Alcon (ALC) Q3 Earnings
- Nov -07 - Alcon Debuts Groundbreaking PRECISION7, a One-Week Replacement Contact Lens to Start and End Every Week Fresh
- Oct -30 - Alcon Inc. (ALC): Among UBS’ Top Tech Based Disruptive Stocks For 2030
- Oct -28 - Alcon Singapore Elevates Associate Experience with Inspiring Engagement Programs
- Oct -15 - Alcon Innovations on Display at AAO 2024 Demonstrate Efficiency and Performance
- Sep -24 - Reasons to Retain Alcon Stock in Your Portfolio for Now
- Sep -20 - Innovation Aids Alcon Stock's Growth Despite Macroeconomic Troubles
- Aug -27 - Alcon Inc. (ALC): One of Oppenheimer’s Top Stock Picks For the Next 12 Months
- Aug -21 - Alcon (ALC) Q2 Earnings Meet Estimates, Revenues Increase Y/Y
- Aug -21 - Alcon shares drop on earnings miss
- Aug -20 - Alcon (ALC) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
- Aug -20 - Alcon Reports Second-Quarter 2024 Results with Strong Growth in Implantables and Contact Lenses
- Aug -20 - Alcon's (ALC) Market Share Gains, New Launches Aid Growth
Business Breakdown
Expected Mid-Term Growth
Segment n°1 -> Surgical
Expected Growth : 3.5 %
What the company do ?
Why we expect these perspectives ?
Alcon's Surgical segment growth of 3.5% is driven by increasing demand for cataract surgeries, expansion in emerging markets, and adoption of advanced technologies such as femtosecond lasers and intraoperative guidance systems. Additionally, the segment benefits from a strong reputation for quality and innovation, as well as strategic partnerships with eye care professionals.
Segment n°2 -> Vision Care
Expected Growth : 4.5 %
What the company do ?
Why we expect these perspectives ?
Alcon's Vision Care segment growth of 4.5% is driven by increasing demand for daily disposable contact lenses, expansion in emerging markets, and a growing presence in the online channel. Additionally, the company's focus on innovation, such as the launch of new products like Dailies Total1, and strategic partnerships are contributing to its growth momentum.
Alcon Inc. Products
| Product Range | What is it ? |
|---|---|
| Surgical | Alcon's surgical portfolio includes a range of products for cataract, refractive, and glaucoma surgeries, such as intraocular lenses, phacoemulsification systems, and viscoelastics. |
| Vitreoretinal | Alcon's vitreoretinal portfolio includes products for the treatment of retinal diseases, such as vitrectomy machines, retinal implants, and surgical instruments. |
| Contact Lenses | Alcon's contact lens portfolio includes a range of daily, monthly, and color contact lenses for correcting vision and enhancing eye health. |
| Ocular Health | Alcon's ocular health portfolio includes products for the treatment of dry eye, glaucoma, and other eye conditions, such as lubricating eye drops and anti-inflammatory medications. |
| Intraocular Lenses | Alcon's intraocular lens portfolio includes a range of lenses for cataract surgery, including monofocal, multifocal, and toric lenses. |
Alcon Inc.'s Porter Forces
Threat Of Substitutes
Alcon Inc. faces moderate threat from substitutes as there are limited alternatives available for its ophthalmic products. However, the company's strong brand presence and patented products reduce the threat of substitutes.
Bargaining Power Of Customers
Alcon Inc. has a diverse customer base, which reduces the bargaining power of individual customers. Additionally, the company's products are often critical to the operations of its customers, making it difficult for them to negotiate prices.
Bargaining Power Of Suppliers
Alcon Inc. relies on a few key suppliers for raw materials and components. While the company has some bargaining power due to its large scale, suppliers may still have some negotiating power due to the specialized nature of the products.
Threat Of New Entrants
The ophthalmic industry has high barriers to entry, including significant research and development costs, regulatory hurdles, and the need for specialized manufacturing facilities. This reduces the threat of new entrants.
Intensity Of Rivalry
The ophthalmic industry is highly competitive, with several established players competing for market share. Alcon Inc. faces intense competition from companies such as Johnson & Johnson, Bausch + Lomb, and CooperVision.
Capital Structure
| Value | |
|---|---|
| Debt Weight | 19.93% |
| Debt Cost | 4.24% |
| Equity Weight | 80.07% |
| Equity Cost | 7.50% |
| WACC | 6.85% |
| Leverage | 24.90% |
Alcon Inc. : Quality Control
Alcon Inc. passed 4 out of 9 key points:
Historical Valuation
Price/Earnings Ratio
Margin Valuation
Peers Valuation
Competitors
| Company | Rational |
|---|---|
| EL.PA | EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in North America, Europe, Latin America, Asia, Oceania, and Africa. It operates in five segments: Wholesale, Retail, Lenses … |
| COLO-B.CO | Coloplast A/S develops and sells intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Interventional Urology, Voice … |
| SAN.PA | Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, … |
| STMN.SW | Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials, and digital solutions for use in … |
| SYNSAM.ST | Synsam AB (publ), through its subsidiaries, operates as an optical retailer in the Nordic Region. The company offers glasses, sunglasses, sports glasses, and contact lenses, as well as glasses and … |
Peers Metrics
DCF BETA
Expected Cash-Flows
Scoring Insights
Peers Group Analysis
🥇
Sanofi
A-Score
1-Year Total Return ->
🥈
EssilorLuxottica
A-Score
1-Year Total Return ->
🥉
Synsam
A-Score
1-Year Total Return ->
4
Coloplast
A-Score
1-Year Total Return ->
5
Alcon
A-Score
1-Year Total Return ->
6
